Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janette Furuzawa-Carballeda

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Cytokine|July 5, 2015
Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel DiseaseGabriela Fonseca-Camarillo, Janette Furuzawa-Carballeda, Jesús K Yamamoto-Furusho
European Journal of Clinical Investigation|March 4, 2011
Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional studyJanette Furuzawa-Carballeda, Guadalupe Lima, Juan Jakez-Ocampo, et al.
Autoimmunity Reviews|February 10, 2007
Autoimmune inflammation from the Th17 perspectiveJanette Furuzawa-Carballeda, María Inés Vargas-Rojas, Antonio R Cabral
Immunologic Research|May 26, 2016
Interleukin 27 is up-regulated in patients with active inflammatory bowel diseaseJanette Furuzawa Carballeda, Gabriela Fonseca Camarillo, Jesús K Yamamoto-Furusho
Journal of Clinical Immunology|December 5, 2012
IL-10-- and IL-20--expressing epithelial and inflammatory cells are increased in patients with ulcerative colitisGabriela Fonseca-Camarillo, Janette Furuzawa-Carballeda, Luis Llorente, et al.
Clinical & Developmental Immunology|November 28, 2013
Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional studyJanette Furuzawa-Carballeda, Gabriela Fonseca-Camarillo, Guadalupe Lima, et al.
Mediators of Inflammation|May 12, 2017
Adipokine Contribution to the Pathogenesis of OsteoarthritisDaniel Azamar-Llamas, Gabriela Hernández-Molina, Bárbara Ramos-Ávalos, et al.
Clinical and Experimental Rheumatology|October 1, 2021
Differential Th follicular cell subsets in minor salivary glands of patients with primary Sjögren's syndrome and systemic lupus erythematosus associated with Sjögren's syndromeGabriela Hernandez-Molina, Virgilia Soto-Abraham, Victor Zamora-Legoff, et al.
The Journal of Rheumatology|February 4, 2003
Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trialJanette Furuzawa-Carballeda, Antonio R Cabral, Martín Zapata-Zuñiga, et al.
Biomed Research International|January 16, 2019
Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel DiseaseGabriela Fonseca-Camarillo, Janette Furuzawa-Carballeda, Emilio Iturriaga-Goyon, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Cytokine|July 5, 2015
Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel DiseaseGabriela Fonseca-Camarillo, Janette Furuzawa-Carballeda, Jesús K Yamamoto-Furusho
European Journal of Clinical Investigation|March 4, 2011
Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional studyJanette Furuzawa-Carballeda, Guadalupe Lima, Juan Jakez-Ocampo, et al.
Autoimmunity Reviews|February 10, 2007
Autoimmune inflammation from the Th17 perspectiveJanette Furuzawa-Carballeda, María Inés Vargas-Rojas, Antonio R Cabral
Immunologic Research|May 26, 2016
Interleukin 27 is up-regulated in patients with active inflammatory bowel diseaseJanette Furuzawa Carballeda, Gabriela Fonseca Camarillo, Jesús K Yamamoto-Furusho
Journal of Clinical Immunology|December 5, 2012
IL-10-- and IL-20--expressing epithelial and inflammatory cells are increased in patients with ulcerative colitisGabriela Fonseca-Camarillo, Janette Furuzawa-Carballeda, Luis Llorente, et al.
Clinical & Developmental Immunology|November 28, 2013
Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional studyJanette Furuzawa-Carballeda, Gabriela Fonseca-Camarillo, Guadalupe Lima, et al.
Mediators of Inflammation|May 12, 2017
Adipokine Contribution to the Pathogenesis of OsteoarthritisDaniel Azamar-Llamas, Gabriela Hernández-Molina, Bárbara Ramos-Ávalos, et al.
Clinical and Experimental Rheumatology|October 1, 2021
Differential Th follicular cell subsets in minor salivary glands of patients with primary Sjögren's syndrome and systemic lupus erythematosus associated with Sjögren's syndromeGabriela Hernandez-Molina, Virgilia Soto-Abraham, Victor Zamora-Legoff, et al.
The Journal of Rheumatology|February 4, 2003
Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trialJanette Furuzawa-Carballeda, Antonio R Cabral, Martín Zapata-Zuñiga, et al.
Biomed Research International|January 16, 2019
Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel DiseaseGabriela Fonseca-Camarillo, Janette Furuzawa-Carballeda, Emilio Iturriaga-Goyon, et al.
Pageof 8